Pubblicazioni

Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study

2025 - NEUROTHERAPEUTICS

Barbuti, Elena; Castiello, Alessia; Pozzilli, Valeria; Carotenuto, Antonio; Tomasso, Ilaria; Moccia, Marcello; Ruggieri, Serena; Borriello, Giovanna; Lanzillo, Roberta; Morra, Vincenzo Brescia; Pozzilli, Carlo; Petracca, Maria

Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program

2024 - MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL

Salvetti, Marco; Wray, Sibyl; Nelles, Gereon; Belviso, Nicholas; Kumar, Achint; Koster, Thijs; Castro-Borrero, Wanda; Vignos, Megan

Safety and efficacy of COVID-19 vaccines in patients on dialysis. a multicentre cohort study in Italy

2023 - JN. JOURNAL OF NEPHROLOGY

Menniti-Ippolito, Francesca; Mele, Alfonso; Da Cas, Roberto; De Masi, Salvatore; Chiarotti, Flavia; Fabiani, Massimo; Baglio, Giovanni; Traversa, Giuseppe; Colavita, Francesca; Castilletti, Concetta; Salomone, Mario; Zoccali, Carmine; Messa, Piergiorgio; Mene', Paolo

Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1Â° generation basal insulins

2022 - NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Buzzetti, R.; Fadini, G. P.; Nicolucci, A.; Larosa, M.; Rossi, M. C.; Cucinotta, D.